25 May 2013
Keywords: Forest Labs, Merz, Mylan, Namenda, Impax, Opana
Article | 23 July 2010
US generic drugmaker Mylan says that it has entered into settlement and license agreements with Forest Laboratories and Merz Pharmaceuticals ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 July 2010
22 July 2010
24 May 2013
© 2013 thepharmaletter.com